- Legal with a prescription
- Wegovy, Zepbound and Saxenda for weight; Ozempic, Mounjaro and Rybelsus for diabetes
- Not authorized for people
- BPC-157, MOTS-c, AOD-9604, CJC-1295, ipamorelin and vials sold as retatrutide
- "Research use only" label
- Does not make a product legal, Health Canada says
- Latest action
- Over 11,400 vials seized under court warrants, announced November 6, 2026
- Bringing them in from abroad
- Residents generally cannot import prescription drugs; non-compliant products get seized
Are peptides legal in Canada? Some are.
Peptide drugs that Health Canada has authorized, like Wegovy, Zepbound and Saxenda, are legal with a prescription1,2. “Research use only” peptides such as BPC-157, MOTS-c, AOD-9604 and CJC-1295/ipamorelin are not authorized for human use and cannot legally be sold to people, whatever the label says3.
Here is the plain version. A peptide is just a short chain of amino acids, so the word covers both a prescription pen from your pharmacy and an unlabelled vial from a website. The law cares about the product, not the word.
If Health Canada has reviewed it and given it a Drug Identification Number (DIN), a pharmacy can sell it to you with a prescription. If it has no DIN, it cannot legally be sold to you as a drug4.
Health Canada’s own wording is that “in Canada, peptides are generally regulated as prescription drugs”3. In 2026 it backed that up with warnings, raids, lab tests and a court injunction.
This guide covers what the law says and what Health Canada found. It also explains what a “research use only” label really means, the rules on bringing peptides in from abroad, and the legal options if your goal is weight loss.
Which peptides are legal in Canada, and which are not
The short answer: a peptide is legal to sell in Canada only if it is an authorized drug. The authorized peptides on sale for weight loss are Wegovy, Zepbound and Saxenda. Everything sold as a “research peptide” falls outside that line.
Health Canada notes that it has authorized a number of peptide drugs for a range of diseases, including insulin, semaglutide and tirzepatide products5. Peptides in face creams are a separate case, because cosmetics follow different rules5.
This table covers the ones people ask about for weight loss. Statuses come from Health Canada’s Drug Product Database and Notice of Compliance records, checked on November 12, 20261,2.
| Product or peptide | Health Canada status | How you can get it legally |
|---|---|---|
| Wegovy (semaglutide) | Authorized for chronic weight management | Prescription, any pharmacy |
| Zepbound (tirzepatide) | Authorized for weight management and sleep apnea in adults with obesity | Prescription, any pharmacy |
| Saxenda (liraglutide) | Authorized for weight management | Prescription, any pharmacy |
| Ozempic, Mounjaro, Rybelsus | Authorized for type 2 diabetes only | Prescription; weight-loss use is off-label |
| Sevmia (generic semaglutide) | Authorized for weight, but not on the market yet | Not available to buy |
| CagriSema | Under Health Canada review | Not available outside trials |
| Retatrutide | Not approved in Canada or the US, not under review | No legal source in Canada |
| Tesamorelin (Egrifta) | Both Canadian DINs cancelled | No product sold in Canada |
| BPC-157, MOTS-c, AOD-9604, CJC-1295, ipamorelin | No Drug Product Database record | No legal source in Canada |
| 5-amino-1MQ | No record (and it is a small molecule, not a peptide) | No legal source in Canada |
The diabetes brands and the weight brands contain the same drugs. Ozempic and Wegovy are both semaglutide, and Mounjaro and Zepbound are both tirzepatide6,7,8.
Our Mounjaro vs Ozempic comparison explains why that split matters. The under-review and not-approved rows come from Health Canada’s list of new drug submissions under review9, and the tesamorelin row from its cancelled DINs1.
What the law says: when selling peptides is illegal in Canada
Three rules in the Food and Drug Regulations decide whether a peptide can be sold. One section of the Food and Drugs Act sets the penalties. You do not need to read the whole statute; these are the lines that matter.
1. No DIN, no sale. Section C.01.014(1) says: “No manufacturer shall sell a drug in dosage form unless a drug identification number has been assigned for that drug”4. A research peptide vial has no DIN.
2. A new drug needs a Notice of Compliance. Section C.08.002(1) says “No person shall sell or advertise a new drug unless” two things have happened. The maker must file a satisfactory submission, and the Minister must issue a Notice of Compliance4.
That is the step where Health Canada reviews trial data on safety and effect. Neither BPC-157 nor MOTS-c has an authorized product in Canada1.
3. Prescription drugs go through a pharmacy. Under section C.01.041(1), only someone entitled by provincial law to dispense a prescription drug may sell it, and only under a prescription4. A gym, a wellness shop or a website that is not a licensed pharmacy does not meet that test.
4. The penalties are large. Breaking the Act or the regulations for a therapeutic product is an offence.
On indictment, the fine can reach $5,000,000, with up to two years in prison, or both. On summary conviction, a first offence can bring a fine of up to $250,00010.
Health Canada sums it up in plain words: “Unauthorized drug products are illegal in Canada”3, and “Selling unauthorized drugs is illegal in Canada”11. Its peptide page adds that “injectable peptides are always classified as drugs”12.
What about the buyer? Every rule above is about selling or advertising, and the import rules covered below are about what crosses the border. None of the sources we read says that owning or using a research peptide is itself a crime, so we will not tell you it is.
That is not the same as saying it is fine. You still carry the health risk, and you may lose the product at the border.
What “research use only” means on a peptide label
When people ask “are peptides legal in Canada”, they usually mean these vials. A “research use only” label is a sales tactic, not a permission, and Health Canada has said so directly.
Products sold as “For Research Use Only – Not for Human Consumption” are still covered by the law, and “this type of labelling does not make these products legal or exempt from regulatory requirements”3. It repeated the point for vials marked “For Research Purposes Only” in November 202613.
Here is what the label does and does not tell you.
- It does not mean the product was tested. Health Canada has not assessed unauthorized products for safety, effect or quality3.
- It does not mean the vial is sterile. No one checked, and Health Canada’s tests found seized products that were not14.
- It does not mean the dose is right. A vial can hold too much, too little or none of the active ingredient14.
- It does not mean the seller is aiming at labs. Some sellers post dosing charts and before-and-after photos right next to a “not for human use” label. That label is not fooling the regulator.
Peptides do have real uses in lab research. But a site that sells to anyone with a credit card and a shipping address, with dosing charts on the same page, is not selling to a lab. On a site like that, the label is a fig leaf.

What Health Canada has done about research peptides in Canada
Health Canada has issued at least nine public advisories about unauthorized peptides since December 2023. The pace picked up in 2026.
It has seized products from online sellers and a Calgary wellness centre, warned about an Ottawa wellness company, and found bacteria in some of the products it tested. We describe sellers by place, not by name, because this site does not point readers to any seller.
| Date | Advisory | What happened | Finding |
|---|---|---|---|
| 2023-12-13 | RA-74731 | Warning about unauthorized injectable drugs, including peptides, sold online by one seller15 | Unauthorized drugs sold to the public |
| 2024-06-26 | RA-75741 | Unauthorized drugs sold on two websites16 | Illegal sale; updated 2024-07-19 |
| 2025-04-01 | RA-77218 | Injectable peptides seized from a Calgary wellness centre17 | BPC-157, CJC-1295, ipamorelin, MOTS-c and others |
| 2025-04-14 | RA-77275 | Injectable peptides sold online from Sherbrooke, Quebec18 | The seller stopped and took its site down |
| 2025-08-01 | RA-77807 | Peptides seized and sold by an online seller11 | Over 40 products named, including AOD-9604, BPC-157, retatrutide, tesamorelin and tirzepatide |
| 2026-01-21 | RA-81518 | Fake or unauthorized GLP-1 drugs in stores and online19 | Semaglutide and tirzepatide products |
| 2026-04-09 | RA-81874 | “Think twice before injecting peptides bought online”3 | General warning naming BPC-157, CJC-1295, ipamorelin, MOTS-c and retatrutide |
| 2026-11-06 | RA-82930 | Peptides from a supplier in Shanghai sold by two Canadian websites20 | Bacteria found (Acinetobacter, Cutibacterium acnes); over 11,400 vials seized under court-issued warrants |
| 2026-11-12 | RA-82944 | Unauthorized peptides sold by an Ottawa wellness company13 | An injectable contaminated with Sphingomonas bacteria; BPC-157, MOTS-c, retatrutide and tesamorelin among the products |
Two more steps sit outside the advisory list. On June 11, 2026, the Superior Court of Québec granted Health Canada a permanent injunction against the same online seller it had warned about in December 2023. The order bars the company from making, testing, distributing, selling or advertising unauthorized injectable peptides, including on websites and social media seen from Canada21.
Health Canada announced it on July 29, 2026. Then, on October 23, 2026, it published a set of web pages just on peptides. They say unauthorized synthetic peptides are now sold widely online, including through social media5.
The tools Health Canada lists show how far it is willing to go. They include recalls, product seizures, requests to stop sales, court-issued entry warrants, permanent court injunctions and ministerial orders to stop advertising and sale12. It also works with the Canada Border Services Agency to stop shipments3.
Can you import research peptides into Canada for personal use?
Not in any way the rules protect. Health Canada has a guidance document on bringing health products into Canada for personal use.
It says that, generally, residents of Canada are not allowed to bring in prescription drugs for people or animals22. Health Canada says injectable peptides are regulated as prescription drugs11, so an injectable vial ordered from a foreign website falls under that rule.
The same guidance says health products found to be non-compliant during inspection “will be refused entry or seized”22. Health Canada says it works with border officers to stop peptide shipments3, so an order may never arrive.
Here are the other points in that guidance22:
- Visitors to Canada may bring a personal quantity of their own prescription drug: no more than a 90-day supply or a single course of treatment, whichever is less.
- The product must be in its original retail package, have its original label, or be in the package a pharmacy or hospital dispensed.
- Prescriptions written outside Canada may not be filled here.
- If you need a drug that has no licensed version in Canada, the guidance points you to your doctor and Health Canada’s Special Access Program.
None of the Health Canada pages we read describes a personal-import exception for research peptides. The visitor allowance covers a person’s own prescribed medicine, not an unauthorized vial bought online.
Are peptides safe for weight loss?
Authorized peptide drugs have been tested in thousands of people, and their risks are written down. Research peptides have not, and Health Canada’s testing of seized vials shows why that gap matters. We will not call any research peptide safe, because no evidence lets anyone say so.
Start with the authorized side. Wegovy’s main trial, STEP 1, followed 1,961 adults for 68 weeks. People on semaglutide lost 14.9% of their body weight, against 2.4% on placebo, and 4.5% stopped because of stomach side effects23.
Zepbound’s trial, SURMOUNT-1, followed 2,539 adults for 72 weeks, with 20.9% weight loss on the top dose against 3.1% on placebo24. Both drugs have known side effects, mostly nausea and diarrhea, and Canadian product monographs that list warnings23,6,8. That is what a reviewed drug looks like: real numbers and real downsides, on paper.
Research peptides have nothing like that. A 2026 review in Sports Medicine found rigorous human safety data for unapproved peptides “are scarce” and warned of potential for serious harm25. Health Canada lists the risks it worries about: hormone and blood-sugar imbalance, liver or kidney damage, blood clots, tumour growth and infection3.
Sterility and contamination
An injection puts whatever is in the vial straight past your skin. If a germ is in the vial, it goes straight into your body, which is why sterility matters so much. In November 2026 Health Canada found Acinetobacter and Cutibacterium acnes bacteria in peptides sold by two Canadian websites20, and Sphingomonas bacteria in an injectable sold in Ottawa13.
It warns that contaminated injectables “can cause serious infections, hospitalization, and in severe cases, life-threatening sepsis”13. It also lists solvents, heavy metals and particles as possible contaminants3.
Dose accuracy and what is really in the vial
Health Canada tested peptides it seized during enforcement work. Some contained no peptides at all, and some lacked the peptide on the label14. Others may contain unlisted or unknown ingredients14.
So even a buyer who follows a seller’s chart has no idea what dose, if any, goes in. This is one more reason we never publish doses for these products.
No trial data for weight loss
None of the popular research peptides has a human trial showing weight loss. MOTS-c prevented diet-induced obesity in mice, and the FDA says it has found no human exposure data26,27. AOD-9604’s development as an obesity drug was ended in 2007 after phase IIb results28.
Human research on BPC-157 is tiny; one published study is a two-person intravenous safety pilot29. CJC-1295 raised growth hormone in healthy adults, but no weight result was reported30. Ipamorelin’s one phase 2 trial, in bowel surgery patients, found no clear benefit over placebo31.
Retatrutide is the odd one out. It has real phase 3 results: 25.0% weight loss on the top dose at 80 weeks in TRIUMPH-1, against 3.9% on placebo32. But that was Lilly’s product, made to drug standards and given in a monitored trial.
The vials sold as “reta” in Canada are unauthorized products with no link to that trial. Retatrutide was also on the product list of the November 6, 2026 advisory in which Health Canada found bacteria in unauthorized peptides20. For how every peptide compares on human evidence, see our graded rankings and how we grade the evidence.
How to check whether a peptide product is authorized
It takes about a minute. An authorized drug has an eight-digit DIN on its label, and you can look that number up in Health Canada’s Drug Product Database3,11.
- Find the DIN on the box or label. It is eight digits. No DIN means it is not an authorized drug.
- Search the number in the database. The record should show the same brand, maker, ingredient and strength as the product in your hand.
- Check the status. “Marketed” means it is on sale in Canada. A cancelled or approved-but-not-marketed product should not be sold to you.
- Ask a pharmacist if anything looks off. They can look the number up for you.
A natural health product carries an NPN instead of a DIN, and Health Canada lists both as signs of an authorized product3. Injectable peptides are always drugs, though12, so an injectable sold with only an NPN, or with no number at all, is a red flag.
How to get peptides legally in Canada for weight loss
If your real goal is weight loss, the legal peptides are also the ones with the strongest evidence. Wegovy, Zepbound and Saxenda are authorized for chronic weight management and sold through Canadian pharmacies with a prescription8,6,33.
Here is the usual path:
- Book a visit with your doctor, or a licensed Canadian online clinic, and ask whether a weight-management drug fits you. Each label sets body mass index (BMI) limits, and Saxenda is meant for people who have tried another weight program first33.
- Fill the prescription at a pharmacy. The pharmacist checks the DIN for you, which settles the authorization question.
- Ask about coverage. Your pharmacist or insurer can tell you whether your plan pays. Cash prices vary by brand, strength and pharmacy34.
Our guide to legal weight-loss injections in Canada walks through each option, what it costs and where to get a prescription. If you are torn between the drugs, comparing the GLP-1s covers that choice.
Six questions about your goals, budget and comfort with needles.
If you already bought or used a research peptide
You are not alone, and Health Canada’s advice is practical rather than scolding. It asks people to speak to a health care provider if they use, or plan to use, peptides. It also warns that putting off medical care can put your health at risk14.
- Stop using it if it came from a seller named in an advisory, or if you cannot confirm what it is.
- Get care fast if you have redness, swelling, fever or chills after an injection. Those can be signs of infection, which Health Canada says can lead to sepsis with contaminated products13.
- Tell your doctor or pharmacist exactly what you took and where it came from. Bring the vial or a photo of the label.
- Be careful with online advice. Health Canada notes that personal stories in online groups are not the same as well-designed studies14.
So, are peptides legal in Canada? The authorized ones are, with a prescription, and a legal prescription is still open to you after this.
Telling your doctor what you tried helps them pick a drug and watch for side effects. Read our medical disclaimer for what this site can and cannot do for you, then take the one-minute quiz to see which authorized treatment might fit.
Frequently asked questions
Is BPC-157 legal in Canada?
BPC-157 is not authorized by Health Canada for human use, and no product containing it is listed in the Drug Product Database. That means it cannot legally be sold to people in Canada. Health Canada has named BPC-157 in four advisories since 2025, including seizures in Calgary and from an online seller, and one warning that covered oral capsules.
Is it legal to buy research peptides in Canada?
Selling them for human use is illegal, and Health Canada says a research use only label does not change that. The law is written around sale, advertising and import, so the sale rules apply to the seller. If you order from abroad, the package can be refused at the border or seized.
Can I bring peptides into Canada from another country?
Health Canada's personal-use guidance says Canadian residents are generally not allowed to bring prescription drugs into Canada, and products that fail inspection are refused entry or seized. Peptides are generally regulated as prescription drugs here. Visitors have a separate allowance for their own prescribed medicine.
Is retatrutide legal in Canada?
No. Retatrutide is an investigational drug from Eli Lilly. Neither Health Canada nor the US FDA has approved it, and it is not under Health Canada review.
Anything sold as retatrutide in Canada today is unauthorized. Health Canada has seized it from sellers and named it in four advisories since 2025.
Are peptides safe for weight loss?
It depends on which peptide. Authorized peptide drugs like Wegovy and Zepbound were tested in large trials and come with a full list of known side effects. Research peptides have no human weight-loss trials, and Health Canada has found seized vials that were not sterile or did not contain what the label said.
How can I tell if a peptide is authorized by Health Canada?
Look for an eight-digit Drug Identification Number (DIN) on the box, then search that number in Health Canada's Drug Product Database. If there is no DIN, or the number does not match the product, it is not an authorized drug. A pharmacist can check it for you too.
Are peptides illegal in Canada?
Not all of them. Selling a peptide that Health Canada has not authorized for human use is illegal, whatever the label on the vial says. Authorized peptide drugs such as Wegovy, Zepbound and Saxenda are legal when a pharmacy fills them on a prescription.
The sale rules are aimed at sellers, and none of the sources we read says that owning or using a research peptide is a crime in itself. An order from abroad can still be seized at the border.
- Drug Product Database (product, status, route, form and active-ingredient records via the DPD API; searched for semaglutide, tirzepatide, liraglutide, tesamorelin, orforglipron, cagrilintide, retatrutide, survodutide, AOD, BPC, MOTS, ipamorelin, CJC, methylquinolinium), Health Canada, accessed 2026-11-12
- Notice of Compliance database (all NOCs for semaglutide, tirzepatide, liraglutide and tesamorelin, via the NOC API), Health Canada, accessed 2026-11-12
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you (RA-81874), Health Canada (public advisory), 2026-04-09
- Food and Drug Regulations (C.R.C., c. 870), sections C.01.014, C.01.041 and C.08.002, Justice Laws Website (Government of Canada), accessed 2026-11-12
- Peptides: Overview, Health Canada, 2026-10-23
- ZEPBOUND (tirzepatide injection) Product Monograph, Eli Lilly Canada Inc. (Health Canada DPD), date of authorization 2026-06-11
- MOUNJARO (tirzepatide injection) Product Monograph, Eli Lilly Canada Inc. (Health Canada DPD), date of authorization 2026-06-23
- WEGOVY (semaglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada DPD), date of authorization 2026-10-02
- Drug and Health Product Submissions Under Review (SUR): New drug submissions under review (list current as of 2026-09-30), Health Canada, page dated 2026-10-23
- Food and Drugs Act (R.S.C. 1985, c. F-27), section 31.2, Justice Laws Website (Government of Canada), accessed 2026-11-12
- Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks (RA-77807), Health Canada (public advisory), 2025-08-01
- Peptides: Regulations and enforcement, Health Canada, 2026-10-23
- Health Canada warns about unauthorized peptides, including contaminated injectable peptides sold by Sage & Summit Wellness Co. in Ottawa, ON (RA-82944), Health Canada (public advisory), 2026-11-12
- Peptides: Health risks, Health Canada, 2026-10-23
- Unauthorized injectable drug products sold online by Canlab Research may pose serious health risks (RA-74731), Health Canada (public advisory), 2023-12-13
- Unauthorized drug products sold illegally on Quadragen and Advanced Research websites may pose serious health risks (RA-75741), Health Canada (public advisory), 2024-06-26 (updated 2024-07-19)
- Unauthorized injectable peptide drugs seized from Optimum Wellness Centre in Calgary, Alberta may pose serious health risks (RA-77218), Health Canada (public advisory), 2025-04-01 (updated 2025-04-02)
- Unauthorized injectable peptide drugs sold by Prime Research may pose serious health risks (RA-77275), Health Canada (public advisory), 2025-04-14
- Thinking about buying GLP-1 drugs like Ozempic or Mounjaro? Beware of fake or unauthorized products (RA-81518), Health Canada (public advisory), 2026-01-21
- Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs (RA-82930), Health Canada (public advisory), 2026-11-06
- Health Canada obtains permanent injunction preventing Canlab Research's illegal sale of injectable peptides in Canada, Health Canada (news release), 2026-07-29
- Bringing health products into Canada for personal use (GUI-0116), Health Canada, 2026-07-13
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine 384(11):989-1002, 2021-03-18
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine 387(3):205-216, 2022-07-21
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance, Sports Medicine 56(8):1921-1935, 2026-08
- Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance, Cell Metabolism 21(3):443-454, 2015-03-03
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, U.S. Food and Drug Administration, content current as of 2026-04-22
- Development of AOD-9604 in obesity terminated following phase IIb results, BioWorld [trade press], 2007-02-26
- Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study, Alternative Therapies in Health and Medicine 31(5):20-24, 2025-09
- Teichman SL et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults, Journal of Clinical Endocrinology & Metabolism 91(3):799-805, 2006-03
- Beck DE et al. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients, International Journal of Colorectal Disease 29(12):1527-1534, 2014-12
- Jastreboff AM et al. Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (TRIUMPH-1), New England Journal of Medicine 395(18):1781-1793, 2026-11-05 (online 2026-09-29)
- SAXENDA (liraglutide injection) Product Monograph, Novo Nordisk Canada Inc. (Health Canada DPD), date of authorization 2025-09-10
- How we price: Canadian cash prices modelled from list prices and each chain's dispensing fee, with drug prices from a published August 2026 retail phone audit where one exists, Peptides for Weight Loss (methodology), 2026-11-12
For information only, not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any treatment. Prices are cash prices before insurance and change often.
Some provider links may earn us a referral fee, which never changes a grade or a ranking. Medical disclaimer · How we source
